Remedent, Inc. Receives Initial Purchase Order From CVS Pharmacy Stores

Main Category: Dentistry
Article Date: 15 Feb 2008 - 16:00 PDT

email to a friend   printer friendly   opinions  

Remedent, Inc. (OTCBB: REMI), an international company specializing in the research, development, manufacturing of oral care and cosmetic dentistry products, announced today that it has received a significant initial purchase order for its iWhite teeth whitening system from CVS Caremark Corporation. Under the terms of the order, Remedent will initially ship this quarter two SKUs per store, one the iWhite Light Activated Teeth Whitening Kit and the other the iWhite Maintenance Stick. In addition to shipping these products to more than 6,200 CVS drug stores for availability on the store shelves in April 2008, Remedent will also deliver each SKU to various CVS warehouses across the U.S.

"We are very pleased to announce this initial purchase order for our proprietary whitening solution, iWhite, with CVS retail stores," stated Mr. Robin List, Chief Executive Officer of Remedent. "This purchase order is a major breakthrough for Remedent in building the Company's presence in the U.S. market. CVS is one of the largest drug store chains in the U.S. and a market leader within the retail industry. To support this initiative, we plan on commencing a cooperative advertising and media campaign with CVS and are hopeful to advancing iWhite into other retail channels in the future."

About Remedent, Inc.

Remedent, Inc., a publicly-traded company on the OTCBB, specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. With offices in California, Belgium and Singapore, Remedent distributes its products in more then 35 countries.

http://www.remedent.com

About CVS Caremark Corporation

CVS Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's leading pharmaceutical services companies with the country's largest pharmacy chain. The company fills or manages more than one billion prescriptions per year, more than any other pharmacy services provider. CVS Caremark drives value for pharmacy services customers by effectively managing pharmaceutical costs and improving healthcare outcomes through its 6,200 CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, http://www.CVS.com.

Forward-Looking Statements

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The statements by Robin List, optimism related to the business, expanding sales, the US and international markets and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products. In addition, actual results could vary materially based on changes or slower growth in the oral care and cosmetic dentistry products market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in the dental industry; unexpected difficulties in penetrating the oral care and cosmetic dentistry products market; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

http://www.remedent.com

• Additional
• References
• Citations